• After the Covid pandemic, we have resumed stem cell treatments. Appropriate sterility and great care in sanitisation is undertaken as usual. If you are unwell with a cough cold or respiratory symptoms it is best to postpone your procedure.

Auto-Immune Diseases Library

Clinical results and second-look arthroscopic findings after treatment with adipose-derived stem cells for knee osteoarthritis

150 150 NZ Stem Cell Treatment Centre

Knee Surg Sports Traumatol Arthrosc 2015 May;23(5):1308-16.   Clinical results and second-look arthroscopic findings after treatment with adipose-derived stem cells for knee osteoarthritis Yong-Gon Koh 1, Yun-Jin Choi, Sae-Kwang Kwon, Yong-Sang Kim, Jee-Eun Yeo Center for Stem Cell and Arthritis Research, Department of Orthopedic Surgery, Yonsei Sarang Hospital, 478-3, Bangbae-dong, Seocho-gu, Seoul, South Korea.  …

read more

What comes first? Multitissue involvement leading to radiographic osteoarthritis: magnetic resonance imaging-based trajectory analysis over four years in the osteoarthritis initiative

150 150 NZ Stem Cell Treatment Centre

Arthritis Rheumatol 2015 May;67(8):2085-96.   What comes first? Multitissue involvement leading to radiographic osteoarthritis: magnetic resonance imaging-based trajectory analysis over four years in the osteoarthritis initiative Frank W Roemer 1, C Kent Kwoh 2, Michael J Hannon 3, David J Hunter 4, Felix Eckstein 5, Tomoko Fujii 3, Robert M Boudreau 3, Ali Guermazi 6 1Boston University School of Medicine, Boston, Massachusetts, and University of Erlangen-Nuremberg, Erlangen, Germany. 2University of…

read more

Human intracerebroventricular (ICV) injection of autologous, non-engineered, adipose-derived stromal vascular fraction (ADSVF) for neurodegenerative disorders: results of a 3-year phase 1 study of 113 injections in 31 patients

150 150 NZ Stem Cell Treatment Centre

Mol Biol Rep 2019 Oct;46(5):5257-5272. Epub 2019 Jul 20. Human intracerebroventricular (ICV) injection of autologous, non-engineered, adipose-derived stromal vascular fraction (ADSVF) for neurodegenerative disorders: results of a 3-year phase 1 study of 113 injections in 31 patients Christopher Duma 1, Oleg Kopyov 2, Alex Kopyov 2, Mark Berman 3, Elliot Lander 3, Michael Elam 3, Michael Arata 3, David Weiland 4, Ruslana Cannell 5, Chad Caraway 5, Sean Berman 3, Kristin Scord 2, Lian Stemler 2, Karlyssa Chung 2, Samuel Khoudari 2, Rory McRory 2, Chace Duma 2, Sawyer…

read more

Autologous Stromal Vascular Fraction: A New Era of Personal Cell Therapy

150 150 NZ Stem Cell Treatment Centre

Journal of Stem Cells Research Development & Therapy, 2018, 4: 011 Autologous Stromal Vascular Fraction: A New Era of Personal Cell Therapy Elliot B Lander and Mark H Berman California Stem Cell Treatment Center, Cell Surgical Network Inc., California, USA   ABSTRACT The fascinating story of Stromal Vascular Fraction (SVF) and its prominent role in autologous…

read more

Mesenchymal stem cells and immunomodulation: toward new immunosuppressive strategies for the treatment of autoimmune diseases?

150 150 NZ Stem Cell Treatment Centre

Rev Med Interne. 2009 Mar;30(3):287-99. Epub 2008 Oct 17. Mesenchymal stem cells and immunomodulation: toward new immunosuppressive strategies for the treatment of autoimmune diseases? [Article in French] Larghero J, Vija L, Lecourt S, Michel L, Verrecchia F, Farge D. Source Unité de thérapie cellulaire, Hôpital Saint-Louis, AP-HP, Paris, France. Abstract Mesenchymal stem cells (MSC) represent…

read more

Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes.

150 150 NZ Stem Cell Treatment Centre

Diabetes Metab. 2009 Apr;35(2):85-93. Epub 2009 Feb 20. Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes. Vija L, Farge D, Gautier JF, Vexiau P, Dumitrache C, Bourgarit A, Verrecchia F, Larghero J. Source Inserm U697, Paris, France. Abstract Mesenchymal stem cells (MSCs) are multipotent non-haematopoietic progenitor cells that are being explored as…

read more

Technology Insight: hematopoietic stem cell transplantation for systemic rheumatic disease.

150 150 NZ Stem Cell Treatment Centre

Nat Clin Pract Rheumatol. 2008 Apr;4(4):184-91 Technology Insight: hematopoietic stem cell transplantation for systemic rheumatic disease. Authors: Nikolov NP, Pavletic SZ Hematopoietic stem cells (HSCs) have the capacity for self-renewal and the potential to differentiate into all types of hematopoietic and immune system cells. These features have been successfully used to treat a multitude of…

read more

Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years’ experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases.

150 150 NZ Stem Cell Treatment Centre

Haematologica. 2010 Feb;95(2):284-92 Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years’ experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. Authors: Farge D, Labopin M, Tyndall A, Fassas A, Mancardi GL, Van Laar J, Ouyang J, Kozak T, Moore J, Kötter I, Chesnel…

read more

The use of stem cells for the treatment of autoimmune diseases.

150 150 NZ Stem Cell Treatment Centre

Braz J Med Biol Res. 2007 Dec;40(12):1579-97 The use of stem cells for the treatment of autoimmune diseases. Authors: Rosa SB, Voltarelli JC, Chies JA, Pranke P Autoimmune diseases constitute a heterogeneous group of conditions commonly treated with anti-inflammatory, immunosuppressant and immunomodulating drugs, with satisfactory results in most cases. Nevertheless, some patients become resistant to…

read more

Haemopoietic stem cell transplantation–an evolving treatment for severe autoimmune and inflammatory diseases in rheumatology, neurology and gastroenterology.

150 150 NZ Stem Cell Treatment Centre

Hematology. 2007 Jun;12(3):179-91 Haemopoietic stem cell transplantation–an evolving treatment for severe autoimmune and inflammatory diseases in rheumatology, neurology and gastroenterology. Authors: Kapoor S, Wilson AG, Sharrack B, Lobo A, Akil M, Sun L, Dalley CD, Snowden JA The concept of haemopoietic stem cell transplantation (HSCT) to treat severe autoimmune diseases has been around for several…

read more